Early reductions may be better detected with dopamine transporter markers.28, 29 Our finding of normal striatal F‐dopa uptake in GBA carriers may not necessarily equate to normal dopamine terminal function, although no GBA carrier exhibited clinical features of PD. The gene discussed is SLC6A3; the disease is Parkinson disease.